(LGND) Ligand Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Ligand Pharmaceuticals | (LGND) share price targets
Complete technical analysis of Ligand Pharmaceuticals (LGND) by charts plus indicators, forecast predictions and share price targets for Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-13 View latest technical analysis
10 day averaged volume of Ligand Pharmaceuticals is 63730
| Date | Daily Closing Price | Open | High | Low | Volume |
| 13 Thu Feb 2025 | 113.93 | 111.76 | 115.99 | 111.52 | 1.062 times |
| 12 Wed Feb 2025 | 111.39 | 110.81 | 112.66 | 110.42 | 1.222 times |
| 11 Tue Feb 2025 | 112.77 | 114.75 | 114.75 | 111.19 | 0.935 times |
| 10 Mon Feb 2025 | 114.12 | 115.12 | 115.75 | 113.03 | 0.833 times |
| 07 Fri Feb 2025 | 115.19 | 117.04 | 118.64 | 113.92 | 1.073 times |
| 06 Thu Feb 2025 | 117.84 | 117.36 | 119.26 | 116.33 | 1.009 times |
| 05 Wed Feb 2025 | 117.31 | 117.92 | 119.11 | 116.49 | 1.127 times |
| 04 Tue Feb 2025 | 117.26 | 114.12 | 117.39 | 113.91 | 0.687 times |
| 03 Mon Feb 2025 | 114.76 | 113.76 | 116.51 | 113.27 | 0.893 times |
| 31 Fri Jan 2025 | 116.55 | 117.85 | 119.38 | 115.00 | 1.067 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 113.3 as stoploss in an intra day buy trade for a target of 115.57. However, stock will show a bearish move below 113.3.
Share price targets for Ligand Pharmaceuticals (LGND)
| Target Type | Value |
| Downside Target | 97.78 |
| Downside Target | 102.79 |
| Downside Target | 105.00 |
| Downside Target | 110.42 |
| Upside Target | 115.99 |
| Upside Target | 119.00 |
| Upside Target | 119.26 |
| Upside Target | 122.34 |
| Upside Target | 125.50 |
| Upside Target | 129.90 |
Intraday share price targets for Ligand Pharmaceuticals (LGND)
| Target Type | Value |
| Downside Intraday Target | 110.9 |
| Downside Intraday Target | 107.88 |
| Upside Intraday Target | 116.47 |
| Upside Intraday Target | 119.02 |
| Downside Intraday Target | 113.45 |
Weekly technical analysis of Ligand Pharmaceuticals (LGND)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 13 Thu Feb 2025 | 113.93 | 115.12 | 115.99 | 110.42 | 0.846 times |
| 07 Fri Feb 2025 | 115.19 | 113.76 | 119.26 | 113.27 | 0.846 times |
| 31 Fri Jan 2025 | 116.55 | 114.75 | 122.34 | 114.75 | 0.96 times |
| 24 Fri Jan 2025 | 115.03 | 113.01 | 119.00 | 112.50 | 4.653 times |
| 17 Fri Jan 2025 | 111.89 | 111.08 | 113.20 | 110.88 | 0.159 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ligand Pharmaceuticals (LGND)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 13 Thu Feb 2025 | 113.93 | 113.76 | 119.26 | 110.42 | 0.293 times |
| 31 Fri Jan 2025 | 116.55 | 108.12 | 122.34 | 102.79 | 0.841 times |
| 31 Tue Dec 2024 | 107.15 | 124.78 | 125.50 | 105.00 | 0.789 times |
| 26 Tue Nov 2024 | 124.33 | 107.05 | 129.90 | 107.05 | 1.406 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ligand Pharmaceuticals (LGND)
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Ligand Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 115.03 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Ligand Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 115.03 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.